The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-1.8% to $320.00
Predicted High$340.00at 1 month
Predicted Low$315.00at 3 months
Max Drawdown (predicted)-3.3%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 17, 2026 12:51 am
Neutral
COHR trends range-bound to
$320.00
(-1.8% from $325.83)
by Feb 2027.
ride-then-fade
ThesisCOHR is a high-beta AI-optics momentum name with no clean valuation anchor; value/quality lenses are negative but sentiment plus risk-on regime dominates near-term. Expect continued upward drift with a mid-window consolidation as valuation gravity bites, then a modest resumption if regime holds.
Invalidated ifBreak below $270 on volume or a regime flip to risk-off would invalidate the continued melt-up; a decisive break above $360 would signal even stronger upside than modeled.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $325.83 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 17, 2026
—
$325.83at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 31, 2026
$257.14–$394.52typical range · internal point $332.00
—
±21.1%
6/10
Momentum and risk-on tape carry AI-optics bid
1 month
Sep 17, 2026
$226.29–$425.37typical range · internal point $340.00
—
±30.5%
5/10
Sentiment peak, high beta amplifies risk-on
2 months
Oct 17, 2026
$328.00
—
+0.7%
4/10
Valuation gravity pulls back after run
3 months
Nov 17, 2026
$315.00
—
-3.3%
4/10
Consolidation as forensic and value drag surface
4 months
Dec 17, 2026
$322.00
—
-1.2%
3/10
Year-end positioning stabilizes high-beta name
5 months
Jan 17, 2027
$330.00
—
+1.3%
3/10
AI capex narrative renewed into CES print
6 months
Feb 17, 2027
$320.00
—
-1.8%
3/10
Mean reversion as risk-on regime ages
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.